Reading International Inc

Reading International is a cinema and entertainment company operating movie theaters in the US, Australia, and New Zealand — not a biotech. Its RNA Therapy classification is a data mismatch. Clinical associations are unrelated to its core theater operations. With 891 insider transactions, management is buying amid the theatrical exhibition industry's post-pandemic recovery. Evaluate on box office trends, premium large format screen expansion, and real estate monetization.

<article class="bts-verified-summary" data-ticker="RDI">
<p>Reading International Inc Class A Common Stock (RDI) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>RDI has 5 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0000716634 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22RDI%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>